Vaccine Coverage and Primary Sjögren'Syndrome
NCT04224454 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 111
Last updated 2020-01-13
Summary
Evaluation of vaccination coverage for influenza, pneumococcus and DTP in patients with pSS and investigated the reasons for non-vaccination.
Conditions
- Primary Sjögren Syndrome
Interventions
- OTHER
-
Questionnaire
Questionnaire was adapted from questionnaires used by the French national agency "Institut de Veille Sanitaire" to study vaccination coverage and were completed with the assistance of one fellow to limit missing data.
Sponsors & Collaborators
-
University Hospital, Montpellier
lead OTHER
Principal Investigators
-
Jacques MOREL, Professor · University Hospital, Montpellier
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-01
- Primary Completion
- 2017-11-01
- Completion
- 2017-11-30
Countries
- France
Study Locations
More Related Trials
-
Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS)
NCT00953485 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.
NCT04830644 ·Status: UNKNOWN ·Phase: PHASE2
-
Inflammatory Myopathies in Primary Sjögren's Syndrome
NCT03126383 ·Status: UNKNOWN
-
Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis
NCT00016458 ·Status: COMPLETED ·Phase: PHASE2
-
A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia
NCT02159651 ·Status: COMPLETED
-
Artificial Intelligence Based Models for Primary Sjögren's Syndrome Diagnosis
NCT06982482 ·Status: COMPLETED
-
A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)
NCT04968912 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis
NCT00533091 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
NCT06455449 ·Status: RECRUITING ·Phase: PHASE3
-
Intravenous Immunoglobulins for the Treatment of Primary Sjögren's Syndrome Associated Painful Sensory Neuropathies
NCT03700138 ·Status: COMPLETED ·Phase: PHASE3
-
Investigating the Morbidity of Glucocorticoid Use in Patients With Autoimmune Bullous Diseases (AIBDs)
NCT05525065 ·Status: UNKNOWN
-
Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis
NCT04789850 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis
NCT05375435 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease
NCT04540497 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy
NCT01727193 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Vaccination Against COVID-19 in Neuromuscular Patients
NCT05311904 ·Status: COMPLETED
-
Neurotrophins Implications in Primary Sjögren Syndrome
NCT01081184 ·Status: COMPLETED
-
TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study
NCT04182984 ·Status: RECRUITING
-
Evaluate the Efficacy of Anti-Jak1 Inhibitors as Treatment for Patients With Aicardi-Goutières Syndrome
NCT06898372 ·Status: COMPLETED
-
Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)
NCT00168025 ·Status: COMPLETED ·Phase: PHASE3
-
JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders
NCT06797024 ·Status: RECRUITING ·Phase: NA
-
Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis
NCT05986162 ·Status: UNKNOWN ·Phase: PHASE1
-
Rituxmab Versus IL-6 in Treating ILD
NCT05963048 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Tissue Repository for Studies of Myasthenia Gravis
NCT02902536 ·Status: COMPLETED
-
Safety, Immunogenicity And Efficacy Of Vaccination In Military Personnel
NCT01807780 ·Status: COMPLETED ·Phase: PHASE4